1.
Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity. JOC [Internet]. 2025 Oct. 10 [cited 2026 Mar. 18];23(1):701-19. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1715